Legend Biotech Corporation
LEGN
$32.80
-$0.66-1.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.12B | 1.21B | 1.29B | 1.30B | 1.31B |
| Total Receivables | 124.89M | 103.98M | 101.38M | 77.96M | 157.06M |
| Inventory | 23.90M | 23.55M | 18.87M | 22.15M | 19.43M |
| Prepaid Expenses | 12.37M | 9.53M | 12.32M | 10.95M | 12.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 70.00K | 583.00K | 431.00K | 359.00K | 357.00K |
| Total Current Assets | 1.28B | 1.35B | 1.42B | 1.41B | 1.50B |
|
|
|||||
| Total Current Assets | 1.28B | 1.35B | 1.42B | 1.41B | 1.50B |
| Net Property, Plant & Equipment | 201.22M | 203.48M | 219.74M | 185.46M | 189.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.16M | 2.51M | 2.77M | 3.15M | 4.06M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 178.49M | 175.29M | 146.44M | 168.32M | 153.16M |
| Total Assets | 1.67B | 1.74B | 1.80B | 1.78B | 1.85B |
|
|
|||||
| Total Accounts Payable | 38.59M | 26.91M | 39.49M | 39.49M | 30.66M |
| Total Accrued Expenses | 64.51M | 141.22M | 132.50M | 110.49M | 61.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.79M | 4.34M | 3.33M | 3.12M | 3.18M |
| Total Finance Division Other Current Liabilities | 169.75M | 98.43M | 118.99M | 96.58M | 121.01M |
| Total Other Current Liabilities | 169.75M | 98.43M | 118.99M | 96.58M | 121.01M |
| Total Current Liabilities | 277.65M | 270.89M | 294.30M | 249.68M | 216.42M |
|
|
|||||
| Total Current Liabilities | 277.65M | 270.89M | 294.30M | 249.68M | 216.42M |
| Long-Term Debt | 301.20M | 296.62M | 291.56M | 286.40M | 281.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.61M | 45.63M | 44.04M | 45.17M | 44.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.15M | 6.58M | 9.28M | 29.80M | 55.32M |
| Total Liabilities | 629.61M | 619.72M | 639.18M | 611.05M | 597.24M |
|
|
|||||
| Common Stock & APIC | 2.70B | 2.69B | 2.68B | 2.65B | 2.64B |
| Retained Earnings | -1.66B | -1.69B | -1.56B | -1.54B | -1.48B |
| Treasury Stock & Other | 6.27M | 118.36M | 46.45M | 62.66M | 98.93M |
| Total Common Equity | 1.04B | 1.12B | 1.16B | 1.16B | 1.25B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 1.12B | 1.16B | 1.16B | 1.25B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 1.12B | 1.16B | 1.16B | 1.25B |
|
|
|||||